196 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Lang AE, Rodriguez RL, Boyd JT, Chouinard S, Zadikoff C, Espay AJ, Slevin JT, Fernandez HH, Lew MF, Stein DA, Odin P, Fung VS, Klostermann F, Fasano A, Draganov PV, et al. Integrated Safety of Levodopa-Carbidopa Intestinal Gel From Prospective Clinical Trials. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26695437 DOI: 10.1002/mds.26485  1
2015 Ojo OO, Fernandez HH. Is it time for flexibility in botulinum inter-injection intervals? Toxicon : Official Journal of the International Society On Toxinology. 107: 72-6. PMID 26440738 DOI: 10.1016/j.toxicon.2015.09.037  1
2015 Fernandez HH. 2015 Update on Parkinson disease. Cleveland Clinic Journal of Medicine. 82: 563-8. PMID 26366951 DOI: 10.3949/ccjm.82gr.15004  1
2015 Fernandez HH, Standaert DG, Chatamra K, Benesh JA. Reply to letter: Suicide in Parkinson's disease patients treated with levodopa-carbidopa Intestinal Gel. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1435-6. PMID 26179940 DOI: 10.1002/mds.26316  1
2015 Genc G, Abboud H, Oravivattanakul S, Alsallom F, Thompson NR, Cooper S, Gostkowski M, Machado A, Fernandez HH. Socioeconomic Status May Impact Functional Outcome of Deep Brain Stimulation Surgery in Parkinson's Disease. Neuromodulation : Journal of the International Neuromodulation Society. PMID 26076401 DOI: 10.1111/ner.12324  1
2015 Abboud H, Floden D, Thompson NR, Genc G, Oravivattanakul S, Alsallom F, Swa B, Kubu C, Pandya M, Gostkowski M, Cooper S, Machado AG, Fernandez HH. Impact of mild cognitive impairment on outcome following deep brain stimulation surgery for Parkinson's disease. Parkinsonism & Related Disorders. 21: 249-53. PMID 25578289 DOI: 10.1016/j.parkreldis.2014.12.018  1
2015 Ojo OO, Fernandez HH. Levodopa/carbidopa intestinal gel: An effective formulation for the management of advanced Parkinson's disease Future Neurology. 10: 191-201. DOI: 10.2217/fnl.15.5  1
2015 Khan TS, Fernandez HH. Traditional pharmacotherapeutic approaches to dystonia: Mode of action of currently used drugs for the treatment of dystonia Dystonia and Dystonic Syndromes. 117-125. DOI: 10.1007/978-3-7091-1516-9_9  1
2015 Shaikh AG, Fernandez HH. Basics of neurostimulation Deep Brain Stimulation. 31-46.  1
2014 Hassan A, Vallabhajosula S, Zahodne LB, Bowers D, Okun MS, Fernandez HH, Hass CJ. Correlations of apathy and depression with postural instability in Parkinson disease. Journal of the Neurological Sciences. 338: 162-5. PMID 24461565 DOI: 10.1016/j.jns.2013.12.040  1
2014 Olanow CW, Kieburtz K, Odin P, Espay AJ, Standaert DG, Fernandez HH, Vanagunas A, Othman AA, Widnell KL, Robieson WZ, Pritchett Y, Chatamra K, Benesh J, Lenz RA, Antonini A, et al. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study. The Lancet. Neurology. 13: 141-9. PMID 24361112 DOI: 10.1016/S1474-4422(13)70293-X  1
2014 Mehanna R, Fernandez HH. Treatment of parkinsonism in patients with non-Parkinson dementia Movement Disorders in Dementias. 61-71. DOI: 10.1007/978-1-4471-6365-7_4  1
2014 Alsallom F, Fernandez HH. Treatment of the elderly with Parkinson's disease: Rationale for using levodopa and practical advice for best management Focus On Parkinson's Disease. 24: 6-15.  1
2013 Ramirez-Castaneda J, Jankovic J, Comella C, Dashtipour K, Fernandez HH, Mari Z. Diffusion, spread, and migration of botulinum toxin. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1775-83. PMID 23868503 DOI: 10.1002/mds.25582  1
2013 Evidente VG, Fernandez HH, LeDoux MS, Brashear A, Grafe S, Hanschmann A, Comella CL. A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomin(®)) in cervical dystonia. Journal of Neural Transmission (Vienna, Austria : 1996). 120: 1699-707. PMID 23779062 DOI: 10.1007/s00702-013-1048-3  1
2013 Fernandez HH, Pagan F, Danisi F, Greeley D, Jankovic J, Verma A, Sethi K, Pappert EJ. Prospective Study Evaluating IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm: Interim Results from the First 145 Subjects with Cervical Dystonia. Tremor and Other Hyperkinetic Movements (New York, N.Y.). 3. PMID 23724362  1
2013 Lim TT, Fernandez HH, Cooper S, Wilson KM, Machado AG. Successful deep brain stimulation surgery with intraoperative magnetic resonance imaging on a difficult neuroacanthocytosis case: case report. Neurosurgery. 73: E184-7; discussion E. PMID 23615095 DOI: 10.1227/01.neu.0000429852.45073.73  1
2013 Fernandez HH, Pappert EJ, Comella CL, Evidente VG, Truong DD, Verma A, Jankovic J. Efficacy and Safety of IncobotulinumtoxinA in Subjects Previously Treated with Botulinum Toxin Versus Toxin-Naïve Subjects with Cervical Dystonia. Tremor and Other Hyperkinetic Movements (New York, N.Y.). 3. PMID 23610743  1
2013 Rodriguez RL, Fernandez HH. Sustained benefit of painful legs moving toes syndrome with botulinum toxin type A. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 20: 1031-2. PMID 23582954 DOI: 10.1016/j.jocn.2012.06.016  1
2013 Truong DD, Gollomp SM, Jankovic J, LeWitt PA, Marx M, Hanschmann A, Fernandez HH. Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin(®)) injections in blepharospasm. Journal of Neural Transmission (Vienna, Austria : 1996). 120: 1345-53. PMID 23435927 DOI: 10.1007/s00702-013-0998-9  1
2013 Fernandez HH, Vanagunas A, Odin P, Espay AJ, Hauser RA, Standaert DG, Chatamra K, Benesh J, Pritchett Y, Hass SL, Lenz RA. Levodopa-carbidopa intestinal gel in advanced Parkinson's disease open-label study: interim results. Parkinsonism & Related Disorders. 19: 339-45. PMID 23287001 DOI: 10.1016/j.parkreldis.2012.11.020  1
2013 Lim TT, Ahmed A, Itin I, Gostkowski M, Rudolph J, Cooper S, Fernandez HH. Is 6 months of neuroleptic withdrawal sufficient to distinguish drug-induced parkinsonism from Parkinson's disease? The International Journal of Neuroscience. 123: 170-4. PMID 23078283 DOI: 10.3109/00207454.2012.732976  1
2013 Cooper SE, McIntyre CC, Fernandez HH, Vitek JL. Association of deep brain stimulation washout effects with Parkinson disease duration. Jama Neurology. 70: 95-9. PMID 23070397 DOI: 10.1001/jamaneurol.2013.581  1
2013 Bernal-Pacheco O, Fernandez HH. Apathy in Parkinson's Disease Current Clinical Neurology. 24: 119-129. DOI: 10.1007/978-1-60761-429-6_7  1
2013 Simuni T, Fernandez HH. Anxiety in Parkinson's Disease Milestones in Drug Therapy. 24: 17-29. DOI: 10.1007/978-1-60761-429-6_2  1
2012 Fernandez HH. Nonmotor complications of Parkinson disease. Cleveland Clinic Journal of Medicine. 79: S14-8. PMID 22761264 DOI: 10.3949/ccjm.79.s2a.03  1
2012 Kluger BM, Parra V, Jacobson C, Garvan CW, Rodriguez RL, Fernandez HH, Fogel A, Skoblar BM, Bowers D, Okun MS. The prevalence of fatigue following deep brain stimulation surgery in Parkinson's disease and association with quality of life. Parkinson's Disease. 2012: 769506. PMID 22666631 DOI: 10.1155/2012/769506  1
2012 Richard IH, McDermott MP, Kurlan R, Lyness JM, Como PG, Pearson N, Factor SA, Juncos J, Serrano Ramos C, Brodsky M, Manning C, Marsh L, Shulman L, Fernandez HH, Black KJ, et al. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology. 78: 1229-36. PMID 22496199 DOI: 10.1212/WNL.0b013e3182516244  1
2012 Oyama G, Rodriguez RL, Jones JD, Swartz C, Merritt S, Unger R, Hubmann M, Delgado A, Simon E, Doniger GM, Bowers D, Foote KD, Fernandez HH, Okun MS. Selection of deep brain stimulation candidates in private neurology practices: referral may be simpler than a computerized triage system. Neuromodulation : Journal of the International Neuromodulation Society. 15: 246-50; discussion 2. PMID 22376158 DOI: 10.1111/j.1525-1403.2012.00437.x  1
2012 Machado A, Fernandez HH, Deogaonkar M. Deep brain stimulation: what can patients expect from it? Cleveland Clinic Journal of Medicine. 79: 113-20. PMID 22301561 DOI: 10.3949/ccjm.78gr.11006  1
2012 Fernandez HH. Updates in the medical management of Parkinson disease. Cleveland Clinic Journal of Medicine. 79: 28-35. PMID 22219231 DOI: 10.3949/ccjm.78gr.11005  1
2012 Bernal-Pacheco O, Limotai N, Go CL, Fernandez HH. Nonmotor manifestations in Parkinson disease. The Neurologist. 18: 1-16. PMID 22217609 DOI: 10.1097/NRL.0b013e31823d7abb  1
2012 Goldman SM, Quinlan PJ, Ross GW, Marras C, Meng C, Bhudhikanok GS, Comyns K, Korell M, Chade AR, Kasten M, Priestley B, Chou KL, Fernandez HH, Cambi F, Langston JW, et al. Solvent exposures and Parkinson disease risk in twins. Annals of Neurology. 71: 776-84. PMID 22083847 DOI: 10.1002/ana.22629  1
2012 Pourcher E, Fernandez HH, Stacy M, Mori A, Ballerini R, Chaikin P. Istradefylline for Parkinson's disease patients experiencing motor fluctuations: results of the KW-6002-US-018 study. Parkinsonism & Related Disorders. 18: 178-84. PMID 22000279 DOI: 10.1016/j.parkreldis.2011.09.023  1
2012 Fernandez HH. Parkinson disease: In reply Cleveland Clinic Journal of Medicine. 79. DOI: 10.3949/ccjm.79c:04007  1
2012 Abboud H, Ahmed A, Fernandez HH. Essential tremor, beta-blockers, and calcium channel blockers: In reply Cleveland Clinic Journal of Medicine. 79: 242. DOI: 10.3949/ccjm.79c:04005  1
2011 Hwynn N, Ul Haq I, Malaty IA, Resnick AS, Dai Y, Foote KD, Fernandez HH, Wu SS, Oyama G, Jacobson CE, Kim SK, Okun MS. Effect of Deep Brain Stimulation on Parkinson's Nonmotor Symptoms following Unilateral DBS: A Pilot Study. Parkinson's Disease. 2011: 507416. PMID 22220288 DOI: 10.4061/2011/507416  1
2011 Abboud H, Ahmed A, Fernandez HH. Essential tremor: choosing the right management plan for your patient. Cleveland Clinic Journal of Medicine. 78: 821-8. PMID 22135272 DOI: 10.3949/ccjm.78a.10178  1
2011 Classen S, Witter DP, Lanford DN, Okun MS, Rodriguez RL, Romrell J, Malaty I, Fernandez HH. Usefulness of screening tools for predicting driving performance in people with Parkinson's disease. The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association. 65: 579-88. PMID 22026326 DOI: 10.5014/ajot.2011.001073  1
2011 Rosales RL, Kanovsky P, Fernandez HH. What's the "catch" in upper-limb post-stroke spasticity: expanding the role of botulinum toxin applications. Parkinsonism & Related Disorders. 17: S3-10. PMID 21999894 DOI: 10.1016/j.parkreldis.2011.06.019  1
2011 Oyama G, Foote KD, Iyer SS, Zeilman P, Hwynn N, Jacobson CE, Malaty IA, Fernandez HH, Rodriguez RL, Okun MS. Unilateral GPi-DBS as a treatment for levodopa-induced respiratory dyskinesia in Parkinson disease. The Neurologist. 17: 282-5. PMID 21881473 DOI: 10.1097/NRL.0b013e318217367b  1
2011 Morishita T, Rahman M, Foote KD, Fargen KM, Jacobson CE, Fernandez HH, Rodriguez RL, Malaty IA, Bowers D, Hass CJ, Katayama Y, Yamamoto T, Okun MS. DBS candidates that fall short on a levodopa challenge test: alternative and important indications. The Neurologist. 17: 263-8. PMID 21881468 DOI: 10.1097/NRL.0b013e31822d1069  1
2011 Shemisa K, Hass CJ, Foote KD, Okun MS, Wu SS, Jacobson CE, Dai Y, Oyama G, Fernandez HH. Unilateral deep brain stimulation surgery in Parkinson's disease improves ipsilateral symptoms regardless of laterality. Parkinsonism & Related Disorders. 17: 745-8. PMID 21856205 DOI: 10.1016/j.parkreldis.2011.07.010  1
2011 Hwynn N, Haq IU, Malaty IA, Resnick AS, Okun MS, Carew DS, Oyama G, Dai Y, Wu SS, Rodriguez RL, Jacobson CE, Fernandez HH. The Frequency of Nonmotor Symptoms among Advanced Parkinson Patients May Depend on Instrument Used for Assessment. Parkinson's Disease. 2011: 290195. PMID 21808724 DOI: 10.4061/2011/290195  1
2011 Dubielecka PM, Hwynn N, Sengun C, Lee S, Lomas-Francis C, Singer C, Fernandez HH, Walker RH. Two McLeod patients with novel mutations in XK. Journal of the Neurological Sciences. 305: 160-4. PMID 21463873 DOI: 10.1016/j.jns.2011.02.028  1
2011 Hicks CW, Pandya MM, Itin I, Fernandez HH. Valproate for the treatment of medication-induced impulse-control disorders in three patients with Parkinson's disease Parkinsonism and Related Disorders. 17: 379-381. PMID 21459656 DOI: 10.1016/j.parkreldis.2011.03.003  1
2011 Hwynn N, Hass CJ, Zeilman P, Romrell J, Dai Y, Wu SS, Foote KD, Subramony SH, Oyama G, Velez-Lago F, Fernandez HH, Resnick AS, Malaty IA, Okun MS. Steady or not following thalamic deep brain stimulation for essential tremor. Journal of Neurology. 258: 1643-8. PMID 21442464 DOI: 10.1007/s00415-011-5986-0  1
2011 Fernandez HH, Odin P. Levodopa-carbidopa intestinal gel for treatment of advanced Parkinson's disease Current Medical Research and Opinion. 27: 907-919. PMID 21351823 DOI: 10.1185/03007995.2011.560146  1
2011 Rosales RL, Ng AR, Santos MM, Fernandez HH. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias. The International Journal of Neuroscience. 121: 44-56. PMID 21348790 DOI: 10.3109/00207454.2011.558260  1
2011 Zahodne LB, Susatia F, Bowers D, Ong TL, Jacobson CE, Okun MS, Rodriguez RL, Malaty IA, Foote KD, Fernandez HH. Binge eating in Parkinson's disease: prevalence, correlates and the contribution of deep brain stimulation. The Journal of Neuropsychiatry and Clinical Neurosciences. 23: 56-62. PMID 21304139 DOI: 10.1176/appi.neuropsych.23.1.56  1
2011 Gil RA, Hwynn N, Fabian T, Joseph S, Fernandez HH. Botulinum toxin type A for the treatment of gastroparesis in Parkinson's disease patients. Parkinsonism & Related Disorders. 17: 285-7. PMID 21296606 DOI: 10.1016/j.parkreldis.2011.01.007  1
2011 Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M, Marras C, Bhudhikanok GS, Kasten M, Chade AR, Comyns K, Richards MB, Meng C, Priestley B, Fernandez HH, et al. Rotenone, paraquat, and Parkinson's disease. Environmental Health Perspectives. 119: 866-72. PMID 21269927 DOI: 10.1289/ehp.1002839  1
2011 Rosales RL, Santos MM, Ng AR, Teleg R, Dantes M, Lee LV, Fernandez HH. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part I): muscle afferent block versus botulinum toxin-A in cervical and limb dystonias. The International Journal of Neuroscience. 121: 35-43. PMID 21244305 DOI: 10.3109/00207454.2010.544435  1
2011 Aguilar JA, Vesagas TS, Jamora RD, Teleg RA, Ledesma L, Rosales RL, Fernandez HH, Lee LV. The promise of deep brain stimulation in X-linked dystonia parkinsonism. The International Journal of Neuroscience. 121: 57-63. PMID 21244299 DOI: 10.3109/00207454.2010.541573  1
2011 Go CL, Rosales RL, Joya-Tanglao M, Fernandez HH. Untreated depressive symptoms among cognitively-intact, community dwelling Filipino patients with Parkinson disease. The International Journal of Neuroscience. 121: 137-41. PMID 21126107 DOI: 10.3109/00207454.2010.537414  1
2011 Fernandez HH, Rosales RL. Uncovering the mystery from the Philippine island of Panay. The International Journal of Neuroscience. 121: 1-2. PMID 21047174 DOI: 10.3109/00207454.2010.526727  1
2011 Oyama G, Rodriguez RL, Fernandez HH, Jacobson CE, Ong TL, Hwynn N, Malaty IA, Okun MS. The distal partial trisomy 1q syndrome and dystonic tremor. Parkinsonism & Related Disorders. 17: 128-9. PMID 21044857 DOI: 10.1016/j.parkreldis.2010.10.004  1
2011 Hwynn N, Fernandez HH. Impulsive and compulsive behaviors in Parkinson disease Uncommon Causes of Movement Disorders. 84-93. DOI: 10.1017/CBO9780511977749.009  1
2010 Troche MS, Okun MS, Rosenbek JC, Musson N, Fernandez HH, Rodriguez R, Romrell J, Pitts T, Wheeler-Hegland KM, Sapienza CM. Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: a randomized trial. Neurology. 75: 1912-9. PMID 21098406 DOI: 10.1212/WNL.0b013e3181fef115  1
2010 Taba HA, Wu SS, Foote KD, Hass CJ, Fernandez HH, Malaty IA, Rodriguez RL, Dai Y, Zeilman PR, Jacobson CE, Okun MS. A closer look at unilateral versus bilateral deep brain stimulation: results of the National Institutes of Health COMPARE cohort. Journal of Neurosurgery. 113: 1224-9. PMID 20849215 DOI: 10.3171/2010.8.JNS10312  1
2010 Zahodne LB, Fernandez HH. Parkinson's psychosis. Current Treatment Options in Neurology. 12: 200-11. PMID 20842582 DOI: 10.1007/s11940-010-0072-y  1
2010 Nocera JR, Price C, Fernandez HH, Amano S, Vallabhajosula S, Okun MS, Hwynn N, Hass CJ. Tests of dorsolateral frontal function correlate with objective tests of postural stability in early to moderate stage Parkinson's disease. Parkinsonism & Related Disorders. 16: 590-4. PMID 20829093 DOI: 10.1016/j.parkreldis.2010.08.008  1
2010 Oyama G, Fernandez HH, Foote KD, Zeilman P, Hwynn N, Jacobson CE, Malaty IA, Rodriguez RL, Okun MS. Differential response of dystonia and parkinsonism following globus pallidus internus deep brain stimulation in X-linked dystonia-parkinsonism (Lubag). Stereotactic and Functional Neurosurgery. 88: 329-33. PMID 20714213 DOI: 10.1159/000319961  1
2010 Troche MS, Fernandez HH. Parkinson disease: sialorrhea and Parkinson disease--novel treatment approaches. Nature Reviews. Neurology. 6: 423-4. PMID 20689564 DOI: 10.1038/nrneurol.2010.107  1
2010 Burdick AP, Fernandez HH, Okun MS, Chi YY, Jacobson C, Foote KD. Relationship between higher rates of adverse events in deep brain stimulation using standardized prospective recording and patient outcomes. Neurosurgical Focus. 29: E4. PMID 20672921 DOI: 10.3171/2010.4.FOCUS10100  1
2010 Jones HN, Kendall DL, Okun MS, Wu SS, Velozo C, Fernandez HH, Spencer KA, Rosenbek JC. Speech motor program maintenance, but not switching, is enhanced by left-hemispheric deep brain stimulation in Parkinson's disease. International Journal of Speech-Language Pathology. 12: 385-98. PMID 20586527 DOI: 10.3109/17549507.2010.491870  1
2010 Nguyen FN, Chang YL, Okun MS, Rodriguez RL, Shapiro MA, Jacobson CE, Swartz CL, Fernandez HH. Prevalence and characteristics of punding and repetitive behaviors among Parkinson patients in North-Central Florida. International Journal of Geriatric Psychiatry. 25: 540-1. PMID 20391589 DOI: 10.1002/gps.2324  1
2010 Wood MF, Nguyen FN, Okun MS, Rodriguez RL, Foote KD, Fernandez HH. The effect of deep brain stimulation surgery on repetitive behavior in Parkinson patients: A case series. Neurocase. 16: 31-6. PMID 20391184 DOI: 10.1080/13554790903193190  1
2010 Sedig L, Leibner J, Ramjit AL, Wu SS, Dai Y, Okun MS, Rodriguez RL, Malaty IA, Fernandez HH. Is rhinorrhea an under-recognized intrinsic symptom of Parkinson disease? A prospective pilot study. The International Journal of Neuroscience. 120: 258-60. PMID 20374072 DOI: 10.3109/00207451003615755  1
2010 Haq IU, Malaty IA, Okun MS, Jacobson CE, Fernandez HH, Rodriguez RR. Clonazepam and botulinum toxin for the treatment of alien limb phenomenon. The Neurologist. 16: 106-8. PMID 20220444 DOI: 10.1097/NRL.0b013e3181a0d670  1
2010 Mikos A, Pavon J, Bowers D, Foote KD, Resnick AS, Fernandez HH, Thomas P, Garvan C, Roy A, Okun MS. Factors related to extended hospital stays following deep brain stimulation for Parkinson's disease. Parkinsonism & Related Disorders. 16: 324-8. PMID 20202888 DOI: 10.1016/j.parkreldis.2010.02.002  1
2010 Voon V, Pessiglione M, Brezing C, Gallea C, Fernandez HH, Dolan RJ, Hallett M. Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors. Neuron. 65: 135-42. PMID 20152119 DOI: 10.1016/j.neuron.2009.12.027  1
2010 Ramjit AL, Sedig L, Leibner J, Wu SS, Dai Y, Okun MS, Rodriguez RL, Malaty IA, Fernandez HH. The relationship between anosmia, constipation, and orthostasis and Parkinson's disease duration: results of a pilot study. The International Journal of Neuroscience. 120: 67-70. PMID 20128674 DOI: 10.3109/00207450903337721  1
2010 Graff-Radford J, Foote KD, Mikos AE, Bowers D, Fernandez HH, Rosado CA, Rodriguez RL, Malaty IA, Haq IU, Jacobson CE, Okun MS. Mood and motor effects of thalamic deep brain stimulation surgery for essential tremor. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 17: 1040-6. PMID 20113336 DOI: 10.1111/j.1468-1331.2010.02958.x  1
2010 Leibner J, Ramjit A, Sedig L, Dai Y, Wu SS, Jacobson C, Okun MS, Rodriguez RL, Malaty IA, Fernandez HH. The impact of and the factors associated with drooling in Parkinson's disease. Parkinsonism & Related Disorders. 16: 475-7. PMID 20064737 DOI: 10.1016/j.parkreldis.2009.12.003  1
2010 Gebere-Michael SG, Johnston JC, Metaferia GZ, Wuhib MZ, Fernandez HH. Bilaterally symmetric cervical spondylotic amyotrophy: a novel presentation and review of the literature. Journal of the Neurological Sciences. 290: 142-5. PMID 20045121 DOI: 10.1016/j.jns.2009.12.009  1
2010 Fernandez HH, Jacobson CE, Okun MS. Converting the UPDRS part III to the Hoehn and Yahr staging may not be adequate for a research database. Parkinsonism & Related Disorders. 16: 150; author reply 15. PMID 19836290 DOI: 10.1016/j.parkreldis.2009.10.002  1
2010 Fernandez HH, Greeley DR, Zweig RM, Wojcieszek J, Mori A, Sussman NM. Istradefylline as monotherapy for Parkinson disease: Results of the 6002-US-051 trial Parkinsonism and Related Disorders. 16: 16-20. PMID 19616987 DOI: 10.1016/j.parkreldis.2009.06.008  1
2010 Bernal-Pacheco O, Fernandez HH. Psychosis Neuropsychiatric and Cognitive Changes in Parkinson's Disease and Related Movement Disorders: Diagnosis and Management. 153-162. DOI: 10.1017/CBO9781139856669.015  1
2009 Fernandez HH, Okun MS, Rodriguez RL, Malaty IA, Romrell J, Sun A, Wu SS, Pillarisetty S, Nyathappa A, Eisenschenk S. Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study. The International Journal of Neuroscience. 119: 2196-205. PMID 19916848 DOI: 10.3109/00207450903222758  1
2009 Classen S, McCarthy DP, Shechtman O, Awadzi KD, Lanford DN, Okun MS, Rodriguez RL, Romrell J, Bridges S, Kluger B, Fernandez HH. Useful field of view as a reliable screening measure of driving performance in people with Parkinson's disease: results of a pilot study. Traffic Injury Prevention. 10: 593-8. PMID 19916131 DOI: 10.1080/15389580903179901  1
2009 Simón-Sánchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, Paisan-Ruiz C, Lichtner P, Scholz SW, Hernandez DG, Krüger R, Federoff M, Klein C, Goate A, Perlmutter J, ... ... Fernandez HH, et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nature Genetics. 41: 1308-12. PMID 19915575 DOI: 10.1038/ng.487  1
2009 Sass JO, Romrell JS, Vinson SY, Fernandez HH, Fischer J, Rodriguez RL, Okun MS. Tracing the origin of L-2-hydroxyglutaric aciduria in a family. The International Journal of Neuroscience. 119: 2118-23. PMID 19863265 DOI: 10.1080/00207450903139655  1
2009 Malaty IA, Fernandez HH. Role of rasagiline in treating Parkinson's disease: Effect on disease progression. Therapeutics and Clinical Risk Management. 5: 413-9. PMID 19753135  1
2009 Stewart KC, Fernandez HH, Okun MS, Alberts JL, Malaty IA, Rodriguez RL, Hass CJ. Effects of dopaminergic medication on objective tasks of deftness, bradykinesia and force control. Journal of Neurology. 256: 2030-5. PMID 19597692 DOI: 10.1007/s00415-009-5235-y  1
2009 Scholz SW, Houlden H, Schulte C, Sharma M, Li A, Berg D, Melchers A, Paudel R, Gibbs JR, Simon-Sanchez J, Paisan-Ruiz C, Bras J, Ding J, Chen H, Traynor BJ, ... ... Fernandez HH, et al. SNCA variants are associated with increased risk for multiple system atrophy. Annals of Neurology. 65: 610-4. PMID 19475667 DOI: 10.1002/ana.21685  1
2009 Stewart KC, Fernandez HH, Okun MS, Rodriguez RL, Jacobson CE, Hass CJ. Side onset influences motor impairments in Parkinson disease. Parkinsonism & Related Disorders. 15: 781-3. PMID 19447063 DOI: 10.1016/j.parkreldis.2009.02.001  1
2009 Susatia F, Fernandez HH. Drug-induced parkinsonism. Current Treatment Options in Neurology. 11: 162-9. PMID 19364450 DOI: 10.1007/s11940-009-0019-3  1
2009 Zahodne LB, Okun MS, Foote KD, Fernandez HH, Rodriguez RL, Wu SS, Kirsch-Darrow L, Jacobson CE, Rosado C, Bowers D. Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus. Journal of Neurology. 256: 1321-9. PMID 19363633 DOI: 10.1007/s00415-009-5121-7  1
2009 Go CL, Rosales RL, Caraos RJ, Fernandez HH. The current prevalence and factors associated with tardive dyskinesia among Filipino schizophrenic patients. Parkinsonism & Related Disorders. 15: 655-9. PMID 19346155 DOI: 10.1016/j.parkreldis.2009.02.015  1
2009 Plowman-Prine EK, Okun MS, Sapienza CM, Shrivastav R, Fernandez HH, Foote KD, Ellis C, Rodriguez AD, Burkhead LM, Rosenbek JC. Perceptual characteristics of Parkinsonian speech: a comparison of the pharmacological effects of levodopa across speech and non-speech motor systems. Neurorehabilitation. 24: 131-44. PMID 19339752 DOI: 10.3233/NRE-2009-0462  1
2009 Okun MS, Fernandez HH, Wu SS, Kirsch-Darrow L, Bowers D, Bova F, Suelter M, Jacobson CE, Wang X, Gordon CW, Zeilman P, Romrell J, Martin P, Ward H, Rodriguez RL, et al. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Annals of Neurology. 65: 586-95. PMID 19288469 DOI: 10.1002/ana.21596  1
2009 Soeder A, Kluger BM, Okun MS, Garvan CW, Soeder T, Jacobson CE, Rodriguez RL, Turner R, Fernandez HH. Mood and energy determinants of quality of life in dystonia. Journal of Neurology. 256: 996-1001. PMID 19277765 DOI: 10.1007/s00415-009-5060-3  1
2009 Mann JM, Foote KD, Garvan CW, Fernandez HH, Jacobson CE, Rodriguez RL, Haq IU, Siddiqui MS, Malaty IA, Morishita T, Hass CJ, Okun MS. Brain penetration effects of microelectrodes and DBS leads in STN or GPi. Journal of Neurology, Neurosurgery, and Psychiatry. 80: 794-7. PMID 19237386 DOI: 10.1136/jnnp.2008.159558  1
2009 Hammond CJ, Fernandez HH, Okun MS. Reflections: neurology and the humanities. A punder in Catch-22. Neurology. 72: 574-5. PMID 19204271 DOI: 10.1212/01.wnl.0000342159.54977.82  1
2009 Kirsch-Darrow L, Zahodne LB, Hass C, Mikos A, Okun MS, Fernandez HH, Bowers D. How cautious should we be when assessing apathy with the Unified Parkinson's Disease Rating Scale? Movement Disorders : Official Journal of the Movement Disorder Society. 24: 684-8. PMID 19185011 DOI: 10.1002/mds.22437  1
2009 Mikos AE, Springer US, Nisenzon AN, Kellison IL, Fernandez HH, Okun MS, Bowers D. Awareness of expressivity deficits in non-demented Parkinson disease. The Clinical Neuropsychologist. 23: 805-17. PMID 19169938 DOI: 10.1080/13854040802572434  1
2009 Zahodne LB, Young S, Kirsch-Darrow L, Nisenzon A, Fernandez HH, Okun MS, Bowers D. Examination of the Lille Apathy Rating Scale in Parkinson disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 677-83. PMID 19133658 DOI: 10.1002/mds.22441  1
2009 Okun MS, Fernandez HH. Will tricyclic antidepressants make a comeback for depressed Parkinson disease patients? Neurology. 72: 868-9. PMID 19092111 DOI: 10.1212/01.wnl.0000338145.24512.02  1
2009 Hooper AK, Okun MS, Foote KD, Haq IU, Fernandez HH, Hegland D, Robicsek SA. Venous air embolism in deep brain stimulation. Stereotactic and Functional Neurosurgery. 87: 25-30. PMID 19039260 DOI: 10.1159/000177625  1
2009 Zahodne LB, Okun MS, Foote KD, Fernandez HH, Rodriguez RL, Kirsch-Darrow L, Bowers D. Cognitive declines one year after unilateral deep brain stimulation surgery in Parkinson's disease: a controlled study using reliable change. The Clinical Neuropsychologist. 23: 385-405. PMID 18821180 DOI: 10.1080/13854040802360582  1
2009 Siddiqui MS, Fernandez HH, Garvan CW, Kirsch-Darrow L, Bowers D, Rodriguez RL, Jacobson CE, Rosado C, Vaidyanathan S, Foote KD, Okun MS. Inappropriate crying and laughing in Parkinson disease and movement disorders. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 10: 234-40. PMID 18609421 DOI: 10.1080/15622970701639445  1
2009 Howe LL, Kellison IL, Fernandez HH, Okun MS, Bowers D. Neuropsychological profile of a Filipino gentleman with X-linked dystonia-parkinsonism: a case report of Lubag disease. The Clinical Neuropsychologist. 23: 100-17. PMID 18609312 DOI: 10.1080/13854040801894714  1
2009 Cooper CA, Jadidian A, Paggi M, Romrell J, Okun MS, Rodriguez RL, Fernandez HH. Prevalence of hypersexual behavior in Parkinson's disease patients: Not restricted to males and dopamine agonist use International Journal of General Medicine. 2: 57-61.  1
2008 Zahodne LB, Fernandez HH. Pathophysiology and treatment of psychosis in Parkinson's disease: a review. Drugs & Aging. 25: 665-82. PMID 18665659 DOI: 10.2165/00002512-200825080-00004  1
2008 Stewart KC, Fernandez HH, Okun MS, Jacobson CE, Hass CJ. Distribution of motor impairment influences quality of life in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1466-8. PMID 18546324 DOI: 10.1002/mds.22162  1
2008 Hooper AK, Okun MS, Foote KD, Fernandez HH, Jacobson C, Zeilman P, Romrell J, Rodriguez RL. Clinical cases where lesion therapy was chosen over deep brain stimulation Stereotactic and Functional Neurosurgery. 86: 147-152. PMID 18334856 DOI: 10.1159/000120426  1
2008 Truong D, Comella C, Fernandez HH, Ondo WG. Efficacy and safety of purified botulinum toxin type A (Dysport®) for the treatment of benign essential blepharospasm: A randomized, placebo-controlled, phase II trial Parkinsonism and Related Disorders. 14: 407-414. PMID 18325821 DOI: 10.1016/j.parkreldis.2007.11.003  1
2008 Okun MS, Rodriguez RL, Foote KD, Sudhyadhom A, Bova F, Jacobson C, Bello B, Zeilman P, Fernandez HH. A case-based review of troubleshooting deep brain stimulator issues in movement and neuropsychiatric disorders Parkinsonism and Related Disorders. 14: 532-538. PMID 18325819 DOI: 10.1016/j.parkreldis.2008.01.001  1
2008 Fernandez HH. What we have learned about sleep disorders and psychosis after nearly two centuries of Parkinson's disease. Summary and conclusions. Cns Spectrums. 13: 34-5. PMID 18323765  1
2008 Zahodne LB, Fernandez HH. Course, prognosis, and management of psychosis in Parkinson's disease: are current treatments really effective? Cns Spectrums. 13: 26-33. PMID 18323764  1
2008 Fernandez HH. Taking a closer look at sleep problems and psychosis in Parkinson's disease. Introduction. Cns Spectrums. 13: 4-5. PMID 18323760  1
2008 Okun MS, Fernandez HH, Foote KD, Murphy TK, Goodman WK. Avoiding deep brain stimulation failures in Tourette syndrome Journal of Neurology, Neurosurgery and Psychiatry. 79: 111-112. PMID 18202200 DOI: 10.1136/jnnp.2007.135715  1
2008 Fernandez HH, Aarsland D, Fénelon G, Friedman JH, Marsh L, Tröster AI, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG. Scales to assess psychosis in Parkinson's disease: Critique and recommendations. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 484-500. PMID 18175343 DOI: 10.1002/mds.21875  1
2008 Chen JJ, Trombetta DP, Fernandez HH. Palliative management of Parkinson disease: Focus on nonmotor, distressing symptoms Journal of Pharmacy Practice. 21: 262-272. DOI: 10.1177/0897190008318370  1
2008 Fernandez HH, McCown KM, Romrell J, Trieschmann ME, Friedman JH, Jacobson IV CE, Okun MS. New-onset diabetes mellitus among parkinsonian patients treated with long-term quetiapine Drug Target Insights. 2008: 27-29.  1
2007 Riggeal BD, Crucian GP, Seignourel P, Jacobson CE, Okun MS, Rodriguez Rl, Fernandez HH. Cognitive decline tracks motor progression and not disease duration in Parkinson patients. Neuropsychiatric Disease and Treatment. 3: 955-8. PMID 19300633  1
2007 Fernandez HH, Chen JJ. Monoamine oxidase-B inhibition in the treatment of Parkinson's disease Pharmacotherapy. 27. PMID 18041937  1
2007 Haq IU, Lewitt PA, Fernandez HH. Apomorphine therapy in Parkinson's disease: a review. Expert Opinion On Pharmacotherapy. 8: 2799-809. PMID 17956200 DOI: 10.1517/14656566.8.16.2799  1
2007 Rodriguez RL, Fernandez HH, Haq I, Okun MS. Pearls in patient selection for deep brain stimulation. The Neurologist. 13: 253-60. PMID 17848865 DOI: 10.1097/NRL.0b013e318095a4d5  1
2007 Chen JJ, Fernandez HH. Community and long-term care management of Parkinson's disease in the elderly: Focus on monoamine oxidase type B inhibitors Drugs and Aging. 24: 663-680. PMID 17702535 DOI: 10.2165/00002512-200724080-00004  1
2007 Kenney C, Fernandez HH, Okun MS. Role of deep brain stimulation targeted to the pedunculopontine nucleus in Parkinson's disease Expert Review of Neurotherapeutics. 7: 585-589. PMID 17563240 DOI: 10.1586/14737175.7.6.585  1
2007 Heilman K, Quencer K, Okun MS, Crucian G, Fernandez HH, Skidmore F. Is decreased dexterity in Parkinson disease due to apraxia? [1] Neurology. 68: 2044. PMID 17548559 DOI: 10.1212/01.wnl.0000268587.29134.ae  1
2007 Fernandez HH, Chen JJ. Monamine oxidase inhibitors: Current and emerging agents for Parkinson disease Clinical Neuropharmacology. 30: 150-168. PMID 17545750 DOI: 10.1097/01.wnf.0000240956.49315.be  1
2007 Okun MS, Fernandez HH, Rodriguez RL, Foote KD. Identifying candidates for deep brain stimulation in Parkinson's disease: The role of the primary care physician Geriatrics. 62: 18-24. PMID 17489644  1
2007 Seignourel PJ, Miller K, Kellison I, Rodriguez R, Fernandez HH, Bauer RM, Bowers D, Okun MS. Abnormal affective startle modulation in individuals with psychogenic [corrected] movement disorder. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 1265-71. PMID 17486611 DOI: 10.1002/mds.21451  1
2007 Halkias IA, Haq I, Huang Z, Fernandez HH. When should levodopa therapy be initiated in patients with Parkinson's disease? Drugs & Aging. 24: 261-73. PMID 17432922 DOI: 10.2165/00002512-200724040-00001  1
2007 Soares-Weiser K, Fernandez HH. Tardive dyskinesia Seminars in Neurology. 27: 159-169. PMID 17390261 DOI: 10.1055/s-2007-971169  1
2007 Okun MS, Rodriguez RL, Foote KD, Fernandez HH. The "chair test" to aid in the diagnosis of psychogenic gait disorders Neurologist. 13: 87-91. PMID 17351529 DOI: 10.1097/01.nrl.0000256358.52613.cc  1
2007 Nguyen FN, Pauly RR, Okun MS, Fernandez HH. Punding as a complication of brain stem stroke? Report of a case Stroke. 38: 1390-1392. PMID 17332454 DOI: 10.1161/01.STR.0000260088.07611.6e  1
2007 Xiromerisiou G, Hadjigeorgiou GM, Eerola J, Fernandez HH, Tsimourtou V, Mandel R, Hellström O, Gwinn-Hardy K, Okun MS, Tienari PJ, Singleton AB. BDNF tagging polymorphisms and haplotype analysis in sporadic Parkinson's disease in diverse ethnic groups. Neuroscience Letters. 415: 59-63. PMID 17229524 DOI: 10.1016/j.neulet.2006.12.038  1
2007 Quencer K, Okun MS, Crucian G, Fernandez HH, Skidmore F, Heilman KM. Limb-kinetic apraxia in Parkinson disease. Neurology. 68: 150-1. PMID 17151340 DOI: 10.1212/01.wnl.0000250331.35912.a5  1
2007 Williams LN, Seignourel P, Crucian GP, Okun MS, Rodriguez RL, Skidmore FM, Foster PS, Jacobson CE, Romrell J, Bowers D, Fernandez HH. Laterality, region, and type of motor dysfunction correlate with cognitive impairment in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 141-5. PMID 17089386 DOI: 10.1002/mds.21220  1
2007 Shapiro MA, Chang YL, Munson SK, Jacobson IV CE, Rodriguez RL, Skidmore FM, Okun MS, Fernandez HH. The four as associated with pathological Parkinson disease gamblers: Anxiety, anger, age, and agonists Neuropsychiatric Disease and Treatment. 3: 161-167. DOI: 10.2147/nedt.2007.3.1.161  1
2007 Seignourel PJ, Miller K, Kellison I, Rodriguez R, Fernandez HH, Bauer RM, Bowers D, Okun MS. Abnormal affective startle modulation in individuals with psychogenic movement disorder (Movement Disorders (2007) 22 (1265-1271) DOI 10.1002/mds.21451)) Movement Disorders. 22: 2139.  1
2006 Scholz S, Mandel RJ, Fernandez HH, Foote KD, Rodriguez RL, Barton E, Munson S, Singleton A, Okun MS. LRRK2 mutations in a clinic-based cohort of Parkinson's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 13: 1298-301. PMID 17116211 DOI: 10.1111/j.1468-1331.2006.01472.x  1
2006 Graff-Radford J, Foote KD, Rodriguez RL, Fernandez HH, Hauser RA, Sudhyadhom A, Rosado CA, Sanchez JC, Okun MS. Deep brain stimulation of the internal segment of the globus pallidus in delayed runaway dyskinesia. Archives of Neurology. 63: 1181-4. PMID 16908749 DOI: 10.1001/archneur.63.8.1181  1
2006 Skidmore FM, Rodriguez RL, Fernandez HH, Goodman WK, Foote KD, Okun MS. Lessons learned in deep brain stimulation for movement and neuropsychiatric disorders Cns Spectrums. 11: 521-537. PMID 16816792  1
2006 Shapiro MA, Chang YL, Munson SK, Okun MS, Fernandez HH. Hypersexuality and paraphilia induced by selegiline in Parkinson's disease: report of 2 cases. Parkinsonism & Related Disorders. 12: 392-5. PMID 16730214 DOI: 10.1016/j.parkreldis.2006.01.010  1
2006 Foote KD, Seignourel P, Fernandez HH, Romrell J, Whidden E, Jacobson C, Rodriguez RL, Okun MS. Dual electrode thalamic deep brain stimulation for the treatment of posttraumatic and multiple sclerosis tremor Neurosurgery. 58. PMID 16582651 DOI: 10.1227/01.NEU.0000192692.95455.FD  1
2006 Chou KL, Fernandez HH. Combating psychosis in Parkinson's disease patients: The use of antipsychotic drugs Expert Opinion On Investigational Drugs. 15: 339-349. PMID 16548784 DOI: 10.1517/13543784.15.4.339  1
2006 Scholz SW, Xiromerisiou G, Fung HC, Eerola J, Hellström O, Papadimitriou A, Hadjigeorgiou GM, Tienari PJ, Fernandez HH, Mandel R, Okun MS, Gwinn-Hardy K, Singleton AB. The human prion gene M129V polymorphism is not associated with idiopathic Parkinson's disease in three distinct populations. Neuroscience Letters. 395: 227-9. PMID 16298483 DOI: 10.1016/j.neulet.2005.10.081  1
2006 Jones HN, Donovan NJ, Sapienza CM, Shrivastav R, Fernandez HH, Rosenbek JC. Expiratory muscle strength training in the treatment of mixed dysarthria in a patient with Lance-Adams syndrome Journal of Medical Speech-Language Pathology. 14: 207-217.  1
2005 Muehlschlegel S, Okun MS, Foote KD, Coco D, Yachnis AT, Fernandez HH. Paraneoplastic chorea with leukoencephalopathy presenting with obsessive-compulsive and behavioral disorder. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 1523-7. PMID 16037914 DOI: 10.1002/mds.20570  1
2005 Ravina B, Putt M, Siderowf A, Farrar JT, Gillespie M, Crawley A, Fernandez HH, Trieschmann MM, Reichwein S, Simuni T. Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study. Journal of Neurology, Neurosurgery, and Psychiatry. 76: 934-9. PMID 15965198 DOI: 10.1136/jnnp.2004.050682  1
2005 Friedman JH, Trieschmann ME, Myers RH, Fernandez HH. Monozygotic twins discordant for Huntington disease after 7 years. Archives of Neurology. 62: 995-7. PMID 15956172 DOI: 10.1001/archneur.62.6.995  1
2005 Okun MS, Tagliati M, Pourfar M, Fernandez HH, Rodriguez RL, Alterman RL, Foote KD. Management of referred deep brain stimulation failures: A retrospective analysis from 2 Movement Disorders Centers Archives of Neurology. 62: 1250-1255. PMID 15956104 DOI: 10.1001/archneur.62.8.noc40425  1
2005 Papapetropoulos S, Mash DC. The neurochemical mechanism of rebound psychosis in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 515; author reply 51. PMID 15747367 DOI: 10.1002/mds.20438  1
2005 Okun MS, Fernandez HH, Foote KD. Deep brain stimulation of the GPi treats restless legs syndrome associated with dystonia Movement Disorders. 20: 500-501. PMID 15593315 DOI: 10.1002/mds.20349  1
2005 Fernandez HH, Trieschmann ME, Okun MS. Rebound psychosis: Effect of discontinuation of antipsychotics in Parkinson's disease Movement Disorders. 20: 104-115. PMID 15390047 DOI: 10.1002/mds.20260  1
2005 Friedman JH, Fernandez HH. Drug-induced movement disorders Movement Disorders. 713-724. DOI: 10.1016/B978-012088382-0/50063-3  1
2004 Fernandez HH, Friedman JH, Lansang MC, Factor SA, Molho ES, Coskun DJ. Diabetes mellitus among parkinsonian patients treated chronically with clozapine. Parkinsonism & Related Disorders. 10: 439-41. PMID 15465403 DOI: 10.1016/j.parkreldis.2004.04.007  1
2004 Wint DP, Okun MS, Fernandez HH. Psychosis in Parkinson's disease Journal of Geriatric Psychiatry and Neurology. 17: 127-136. PMID 15312276 DOI: 10.1177/0891988704267457  1
2004 Al-Yacoub M, Friedman JH, Fernandez HH. Hemiballismus from a parietal stroke in a Parkinson patient Movement Disorders. 19: 986-988. PMID 15300673 DOI: 10.1002/mds.20204  1
2004 Fernandez HH, Donnelly EM, Friedman JH. Long-term outcome of clozapine use for psychosis in parkinsonian patients Movement Disorders. 19: 831-833. PMID 15254945 DOI: 10.1002/mds.20051  1
2004 Fernandez HH, Lannon MC, Trieschmann ME, Friedman JH. Botulinum toxin type B for gait freezing in Parkinson's disease Medical Science Monitor. 10. PMID 15232500  1
2004 Fernandez HH, Trieschmann ME, Friedman JH. Aripraxole for Drug-induced Psychosis in Parkinson Disease: Preliminary Experience Clinical Neuropharmacology. 27: 4-5. PMID 15090928 DOI: 10.1097/00002826-200401000-00003  1
2004 Woods RJ, Cervone RL, Fernandez HH. Common neurologic disorders affecting the foot Journal of the American Podiatric Medical Association. 94: 104-117. PMID 15028788  1
2004 Friedman JH, Fernandez HH, Trieschmann MM. Parkinsonism in a Nursing Home: Underrecognition Journal of Geriatric Psychiatry and Neurology. 17: 39-41. PMID 15018697 DOI: 10.1177/0891988703262001  1
2003 Friedman JH, Fernandez HH, Sudarsky LR. REM behavior disorder and excessive daytime somnolence in Machado-Joseph disease (SCA-3) Movement Disorders. 18: 1520-1522. PMID 14673890 DOI: 10.1002/mds.10590  1
2003 Fernandez HH, Wu CK, Ott BR. Pharmacotherapy of dementia with Lewy bodies Expert Opinion On Pharmacotherapy. 4: 2027-2037. PMID 14596656 DOI: 10.1517/14656566.4.11.2027  1
2003 Romrell J, Fernandez HH, Okun MS. Rationale for current therapies in Parkinson's disease Expert Opinion On Pharmacotherapy. 4: 1747-1761. PMID 14521485 DOI: 10.1517/eoph.4.10.1747.22332  1
2003 Fernandez HH, Trieschmann ME, Friedman JH. Treatment of psychosis in Parkinson's disease: Safety considerations Drug Safety. 26: 643-659. PMID 12814332 DOI: 10.2165/00002018-200326090-00004  1
2003 Fernandez HH, Friedman JH. Classification and treatment of tardive syndromes Neurologist. 9: 16-27. PMID 12801428 DOI: 10.1097/01.nrl.0000038585.58012.97  1
2003 Fernandez HH, Trieschmann ME, Burke MA, Jacques C, Friedman JH. Long-term outcome of quetiapine use for psychosis among Parkinsonian patients. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 510-4. PMID 12722164 DOI: 10.1002/mds.10374  1
2003 Friedman JH, Skeete R, Fernandez HH. Unrecognized Parkinsonism in acute care medical patients receiving neurological consultations [3] Journals of Gerontology - Series a Biological Sciences and Medical Sciences. 58: 94-95. PMID 12560420  1
2002 Fernandez HH, Friedman JH, Ribeiro MJ, Vidailhet M, Remy P. 18F-dopa vs dopamine transporter ligands in positron emission tomographic and single-photon emission computed tomographic scans for Parkinson disease [1] (multiple letters) Archives of Neurology. 59: 1973-1974. PMID 12470189 DOI: 10.1001/archneur.59.12.1973  1
2002 Friedman JH, Fernandez HH. Atypical antipsychotics in Parkinson-sensitive populations Journal of Geriatric Psychiatry and Neurology. 15: 156-170. PMID 12230086  1
2002 Fernandez HH, Trieschmann ME, Burke MA, Friedman JH. Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies Journal of Clinical Psychiatry. 63: 513-515. PMID 12088163  1
2002 Friedman JH, Fernandez HH, Sikirica M, Stopa E, Friehs G. Stroke induced by gamma knife pallidotomy: Autopsy result Neurology. 58: 1695-1697. PMID 12058106  1
2002 Cahn-Weiner DA, Grace J, Ott BR, Fernandez HH, Friedman JH. Cognitive and behavioral features discriminate between Alzheimer's and Parkinson's disease Neuropsychiatry, Neuropsychology and Behavioral Neurology. 15: 79-87. PMID 12050470  1
2002 Fernandez HH, Lapane KL. Predictors of mortality among nursing home residents with a diagnosis of Parkinson's disease Medical Science Monitor. 8. PMID 11951064  1
2001 Fernandez HH, Tabamo REJ, David RR, Friedman JH. Predictors of depressive symptoms among spouse caregivers in Parkinson's disease Movement Disorders. 16: 1123-1125. PMID 11748746 DOI: 10.1002/mds.1196  1
2001 Fernandez HH, Friedman JH, Fischman AJ, Noto RB, Lannon MC. Is altropane SPECT more sensitive to fluoroDOPA PET for detecting early Parkinson's disease? Medical Science Monitor. 7: 1339-1343. PMID 11687754  1
2001 Friedman JH, Fernandez HH. Autopsy follow-up of a patient with schizophrenia and presumed idiopathic Parkinson's disease Clinical Neuropharmacology. 24: 120-121. PMID 11307051 DOI: 10.1097/00002826-200103000-00012  1
2001 Fernandez HH, Krupp B, Friedman JH. The course of tardive dyskinesia and parkinsonism in psychiatric inpatients: 14-Year follow-up Neurology. 56: 805-807. PMID 11274325  1
2001 Friedman JH, Fernandez HH, Factor SA, Rangu S, Rowland FN. Treatment of psychosis in parkinson's disease (multiple letters) Journal of the American Medical Directors Association. 2: 99-100.  1
2000 David RR, Fernandez HH. Quetiapine for hypnogogic musical release hallucinations Journal of Geriatric Psychiatry and Neurology. 13: 210-211. PMID 11128061  1
2000 Fernandez HH, Lapane KL. Estrogen use among nursing home residents with a diagnosis of Parkinson's disease Movement Disorders. 15: 1119-1124. PMID 11104194 DOI: 10.1002/1531-8257(200011)15:6<1119::AID-MDS1009>3.0.CO;2-0  1
2000 Fernandez HH. Quetiapine for L-dopa-induced psychosis in PD [2] (mutiple letters) Neurology. 55: 899. PMID 10994027  1
2000 Durso R, Evans JE, Josephs E, Szabo G, Evans B, Fernandez HH, Browne TR. Variable absorption of carbidopa affects both peripheral and central levodopa metabolism. Journal of Clinical Pharmacology. 40: 854-60. PMID 10934669  1
2000 Fernandez HH, Friedman JH, Famiglietti EV. Probable Cornelia de Lange syndrome with progressive parkinsonism and dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. 15: 749-51. PMID 10928594 DOI: 10.1002/1531-8257(200007)15:4<749::AID-MDS1028>3.0.CO;2-P  1
2000 Tabamo RE, Fernandez HH, Friedman JH, Simon DK. Young-onset Parkinson's disease: a clinical pathologic description of two siblings. Movement Disorders : Official Journal of the Movement Disorder Society. 15: 744-6. PMID 10928592 DOI: 10.1002/1531-8257(200007)15:4<744::AID-MDS1026>3.0.CO;2-#  1
2000 Fernandez HH, Lannon MC, Friedman JH, Abbott BP. Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease Movement Disorders. 15: 579-581. PMID 10830427 DOI: 10.1002/1531-8257(200005)15:3<579::AID-MDS1024>3.0.CO;2-0  1
2000 Fernandez HH, Lapane KL, Ott BR, Friedman JH. Gender differences in the frequency and treatment of behavior problems in Parkinson's disease Movement Disorders. 15: 490-496. PMID 10830414 DOI: 10.1002/1531-8257(200005)15:3<490::AID-MDS1011>3.0.CO;2-E  1
2000 Tabamo RE, Fernandez HH, Friedman JH, Lucas PR. Spinal surgery for severe scoliosis in Parkinson's disease Medicine and Health, Rhode Island. 83: 114-115. PMID 10821012  1
2000 Fernandez HH, Friedman JH, Grace J, Beason-Hazen S. Donepezil for Huntington's disease Movement Disorders. 15: 173-176. PMID 10634264 DOI: 10.1002/1531-8257(200001)15:1<173::AID-MDS1032>3.0.CO;2-T  1
2000 Friedman JH, Fernandez HH. The nonmotor problems of Parkinson's disease Neurologist. 6: 18-27.  1
1999 Lapane KL, Fernandez HH, Friedman JH. Prevalence, clinical characteristics, and pharmacologic treatment of Parkinson's disease in residents in long-term care facilities Pharmacotherapy. 19: 1321-1327. PMID 10555938  1
1999 Fernandez HH, Friedman JH. Funding on L-Dopa Movement Disorders. 14: 836-838. PMID 10495047 DOI: 10.1002/1531-8257(199909)14:5<836::AID-MDS1018>3.0.CO;2-0  1
1999 Fernandez HH, Friedman JH. Carvedilol-induced myoclonus [3] Movement Disorders. 14: 703. PMID 10435516 DOI: 10.1002/1531-8257(199907)14:4<703::AID-MDS1029>3.0.CO;2-G  1
1999 Fernandez HH, Friedman JH, Centofanti JV. Benedikt's syndrome with delayed-onset rubral tremor and hemidystonia: A complication of tic douloureux surgery Movement Disorders. 14: 695-697. PMID 10435512 DOI: 10.1002/1531-8257(199907)14:4<695::AID-MDS1024>3.0.CO;2-3  1
1999 Fernandez HH, Friedman JH, Jacques C, Rosenfeld M. Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 14: 484-7. PMID 10348474 DOI: 10.1002/1531-8257(199905)14:3<484::AID-MDS1016>3.0.CO;2-B  1
1999 Fernandez HH, Friedman JH. The role of atypical antipsychotics in the treatment of movement disorders Cns Drugs. 11: 467-483. DOI: 10.2165/00023210-199911060-00005  1
1998 Fernandez HH, Friedman JH. New anti-parkinsonian drugs Medicine and Health, Rhode Island. 81: 237-238. PMID 9689788  1
1998 Fernandez HH, Durso R. Clozapine for dopaminergic-induced paraphilias in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 13: 597-8. PMID 9613761 DOI: 10.1002/mds.870130338  1
Show low-probability matches.